4
Total investments
3
Early stage
0
Mid stage
1
Late stage
7y
Years active
Portfolio
4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Jul 2020
At Quibim, we design pioneering tools that unlock imaging data to improve patient outcomes. Our main purpose is the application of AI techniques to medical images from MRI, CT, PET to unlock new data which can be transformed into actionable predictions for life sciences and providers.
Board Member
Jun 2020
DeepSpin is developing a next-gen, AI-powered MRI imaging machine at a fraction of the cost, size and weight of standard systems.
Unleashing the power of generative topological design for our hardware and super-resolution deep learning on MRI images, we are taking medical imaging to the digital age.
Through our proprietary technology, we will be making MRI accessible to every patient globally. Join us in the journey to becoming the imaging standard of care in a myriad of previously inaccessible medical domains.
Board Member
Oct 2019
Mindpeaks mission is to enable personalised cancer treatment through AI tissue diagnostics
Our partners are leading pathology and university labs. Our team consists of world-class industry experts in machine learning and company building.
Mindpeaks Impact
The demand for medical image analysis is growing rapidly but the number of cancer experts remains the same - this results in growing workloads per specialist. We help cancer experts meet this challenge.
We build automation tools for visual diagnosis using state-of-the-art artificial intelligence and deep learning. Our tools assist cancer experts in providing reliable and reproducible diagnoses. This frees specialists from tedious, repetitive tasks such as quantification of cells or biomarkers and allows them to focus on tasks where their human expertise is indispensable.
If you want to get in touch with us send us an E-Mail via info@mindpeak.ai.
Experience · 9 entries
All (9)
Investments (4)
Founder (3)
Board (4)
2020
Board Member
Jul 2020
At Quibim, we design pioneering tools that unlock imaging data to improve patient outcomes. Our main purpose is the application of AI techniques to medical images from MRI, CT, PET to unlock new data which can be transformed into actionable predictions for life sciences and providers.
Board Member
Jun 2020
DeepSpin is developing a next-gen, AI-powered MRI imaging machine at a fraction of the cost, size and weight of standard systems.
Unleashing the power of generative topological design for our hardware and super-resolution deep learning on MRI images, we are taking medical imaging to the digital age.
Through our proprietary technology, we will be making MRI accessible to every patient globally. Join us in the journey to becoming the imaging standard of care in a myriad of previously inaccessible medical domains.
Radiologist & Owner
2020
We are a highly specialized radiological, phlebological, and aesthetic practice. We specialize in vein medicine, spinal pain and herniated discs, ultrasound, and ultrasound-targeted hyaluronic fillers, and Botox® injections.
2019
Board Member
Oct 2019
Mindpeaks mission is to enable personalised cancer treatment through AI tissue diagnostics
Our partners are leading pathology and university labs. Our team consists of world-class industry experts in machine learning and company building.
Mindpeaks Impact
The demand for medical image analysis is growing rapidly but the number of cancer experts remains the same - this results in growing workloads per specialist. We help cancer experts meet this challenge.
We build automation tools for visual diagnosis using state-of-the-art artificial intelligence and deep learning. Our tools assist cancer experts in providing reliable and reproducible diagnoses. This frees specialists from tedious, repetitive tasks such as quantification of cells or biomarkers and allows them to focus on tasks where their human expertise is indispensable.
If you want to get in touch with us send us an E-Mail via info@mindpeak.ai.
Show all 9 entries ↓
Investment activity
2019–2020 · 4 investments
Recent (last 2 years)Earlier